EpiCypher is Drug Discovery in United States that focus on chromatin biology research business. Founded in 2012. They cover business area such as developer, technology, drug, product, epigenetic, chromatin biology research, designer recombinant nucleosome, define post-translational modification, chromatin-modify enzyme, ptm-bind protein, readout, nucleosome or peptide-base substrate, researcher.
2012
( 12 years old in 2024 )
Chromatin Biology Research
-
PO Box 14453
Durham, NC 27709
United States
Private
developertechnologydrugproductepigeneticchromatin biology researchdesigner recombinant nucleosomedefine post-translational modificationchromatin-modify enzymeptm-bind proteinreadoutnucleosome or peptide-base substrateresearcher
* We use standard office opening hours in near EpiCypher's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EpiCypher is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), EpiCypher business is focusing on Chromatin Biology Research.
EpiCypher headquarter office and corporate office address is located in PO Box 14453 Durham, NC 27709 United States.
EpiCypher was founded in United States.
In 2024, EpiCypher is currently focus on chromatin biology research sector.
Above is snippet of Google Trends for "chromatin biology research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with EpiCypher, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.